Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Wednesday 13 May, 2020

JP Morgan Sec LLC

Willis Towers Watson plc 8.3

RNS Number : 8010M
J.P. Morgan Securities LLC
13 May 2020
 

Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL 

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

Willis Towers Watson plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

12 May 2020

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

 815,924  0.63

1,312,508  1.02

(2) Derivatives (other than options)

 684,663  0.53

759,675  0.59

(3)Optionsandagreementstopurchase/sell

 

 

Total

 1,500,587  1.16

2,072,183  1.61

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit  (USD)

 

(Note 5)

 

Purchase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sale

1,287

12

26

1

4

3

20

10

991

2,918

5

1

1

1

35

3

3

2

22

900

900

1

2

602

5

 

205

3,314

515

24

101

9

991

192

2,918

35

2,288

700

16

35

10

900

602

100

13

200.7900

201.0050

201.0173

201.0600

201.0700

201.3300

201.3350

201.3420

201.3463

201.4261

201.4340

201.5400

201.5800

201.5900

201.6629

201.6767

201.6800

201.7000

201.7100

201.7344

201.7394

201.7900

201.7950

201.8000

201.8140

 

200.7783

200.7900

200.8809

201.0050

201.0450

201.0750

201.3463

201.3800

201.4261

201.4401

201.5363

201.5525

201.6200

201.6629

201.7100

201.7394

201.8000

201.8300

201.8700

 

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit   (USD) (Note 5)

Equity Swap

Long

 

 

 

Short

12

991

2,918

 

10

900

201.0050

201.3463

201.4261

 

201.7100

201.7394

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

 

 

 

 

 

 

 

 

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and 

any other person relating to the voting rights of any relevant securities under any option referred to 

on   this   form   or   relating   to   the   voting   rights   or   future   acquisition   or   disposal   of   any  relevant securities to 

which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    NO

 

Dateofdisclosure

13 May 2020

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEFXLFFBELXBBD

a d v e r t i s e m e n t